Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Fagan

Showing results (41-50 of 489) with videos related to

Pageof 49
Sort By:
Biomarkers in Medicine|April 3, 2010
Cerebrospinal fluid biomarkers of Alzheimer's diseaseAnne M Fagan, David M Holtzman
Arizona Medicine|October 1, 1978
Steroid myopathyJ M Fagan, L Z Stern
The Biochemical Journal|May 1, 1985
The rate of protein degradation in isolated skeletal muscle does not correlate with reduction-oxidation statusJ M Fagan, A L Goldberg
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 1, 1991
Ventriculo-pulmonary fistula. Case report, literature review and possible surgical approach to the infected LV suture lineP K Sarkar, A M Fagan
Behavioural Brain Research|July 1, 1986
Learning sets, discrimination reversal, and hippocampal functionA M Fagan, D S Olton
Life Sciences|January 1, 1991
Effect of beta agonists on protein turnover in adipose tissueK L Rogers, J M Fagan
The American Journal of Medicine|July 13, 2001
Expectations of and for the medical director of the resident's ambulatory clinicJ G Wong, M Fagan, J Pinsker, et al.
Cold Spring Harbor Perspectives in Medicine|September 7, 2012
Fluid biomarkers in Alzheimer diseaseKaj Blennow, Henrik Zetterberg, Anne M Fagan
The Lancet. Neurology|September 13, 2013
Preclinical Alzheimer's disease criteriaAnne M Fagan, Stephanie J B Vos
The Lancet. Neurology|November 25, 2015
Alzheimer's disease biomarker statesStephanie J B Vos, Anne M Fagan
Pageof 49

Showing results (41-50 of 489) with videos related to

Sort By:
Pageof 49
Biomarkers in Medicine|April 3, 2010
Cerebrospinal fluid biomarkers of Alzheimer's diseaseAnne M Fagan, David M Holtzman
Arizona Medicine|October 1, 1978
Steroid myopathyJ M Fagan, L Z Stern
The Biochemical Journal|May 1, 1985
The rate of protein degradation in isolated skeletal muscle does not correlate with reduction-oxidation statusJ M Fagan, A L Goldberg
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 1, 1991
Ventriculo-pulmonary fistula. Case report, literature review and possible surgical approach to the infected LV suture lineP K Sarkar, A M Fagan
Behavioural Brain Research|July 1, 1986
Learning sets, discrimination reversal, and hippocampal functionA M Fagan, D S Olton
Life Sciences|January 1, 1991
Effect of beta agonists on protein turnover in adipose tissueK L Rogers, J M Fagan
The American Journal of Medicine|July 13, 2001
Expectations of and for the medical director of the resident's ambulatory clinicJ G Wong, M Fagan, J Pinsker, et al.
Cold Spring Harbor Perspectives in Medicine|September 7, 2012
Fluid biomarkers in Alzheimer diseaseKaj Blennow, Henrik Zetterberg, Anne M Fagan
The Lancet. Neurology|September 13, 2013
Preclinical Alzheimer's disease criteriaAnne M Fagan, Stephanie J B Vos
The Lancet. Neurology|November 25, 2015
Alzheimer's disease biomarker statesStephanie J B Vos, Anne M Fagan
Pageof 49